Amplia Therapeutics Limited (ASX:ATX)
John Lambert
MD & CEO
Market Cap (AUD): 19.01M
Sector: Health Care
Last Trade (AUD):
0.098 +0 (+0%)
Tab Bar
1. About
Amplia Therapeutics Limited (ASX:ATX) is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis.
FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic cancer.
FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).